MedTrace Logo

Clinical and Refractive Outcomes After Contoura® Refractive Surgery Planned Using Phorcides Surgery Planning Software

NCT04495829 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-07-20

Study results available
· View outcomes & findings →

Summary

The objective of the current study is to prospectively evaluate 3-month clinical outcomes from LASIK performed using the Phorcides surgical planning software with Contoura topography-guided ablation in both eyes of subjects with myopia and myopic astigmatism seeking refractive surgery for distance correction.

Conditions

  • Refractive Errors

Interventions

DEVICE

Phorcides Analytical Engine

Surgery planning using the Phorcides analytical engine.

Sponsors & Collaborators

  • Science in Vision

    collaborator OTHER

  • Alcon Research

    collaborator INDUSTRY

  • American Corneal Consultants

    lead OTHER

Principal Investigators

  • Robert D Stulting · Woolfson Eye Institute

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-24
Primary Completion
2021-04-21
Completion
2021-04-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04495829 on ClinicalTrials.gov